{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T07:26:29Z","timestamp":1774077989583,"version":"3.50.1"},"reference-count":83,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T00:00:00Z","timestamp":1762041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoporosis and Sarcopenia"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.afos.2025.11.001","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:29:51Z","timestamp":1763987391000},"page":"111-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Asian Federation of Osteoporosis Societies 2025 consensus on atypical femoral fractures in patients with osteoporosis"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9777-5411","authenticated-orcid":false,"given":"Thanut","family":"Valleenukul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thawee","family":"Songpatanasilp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Unnop","family":"Jaisamrarn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surapong","family":"Anuraklekha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5311-7657","authenticated-orcid":false,"given":"Varalak","family":"Srinonprasert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6056-3559","authenticated-orcid":false,"given":"Sumapa","family":"Chaiamnuay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5742-298X","authenticated-orcid":false,"given":"Aasis","family":"Unnanuntana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalita","family":"Wattanachanya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hataikarn","family":"Nimitphong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8643-8198","authenticated-orcid":false,"given":"Noratep","family":"Kulachote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ong-art","family":"Phruetthiphat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahat","family":"Jarayabhand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2148-3921","authenticated-orcid":false,"given":"Tanawat","family":"Amphansap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3731-958X","authenticated-orcid":false,"given":"Ekasame","family":"Vanitcharoenkul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0287-222X","authenticated-orcid":false,"given":"Pojchong","family":"Chotiyarnwong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6844-5431","authenticated-orcid":false,"given":"Kwang-kyoun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0474-3667","authenticated-orcid":false,"given":"Swan Sim","family":"Yeap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3470-7015","authenticated-orcid":false,"given":"Sharmila Sunita","family":"Paramasivam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3699-2406","authenticated-orcid":false,"given":"Linsey","family":"Gani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Lung","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1626-9747","authenticated-orcid":false,"given":"Julie","family":"Li-Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0622-8287","authenticated-orcid":false,"given":"Mark Anthony","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8941-4792","authenticated-orcid":false,"given":"Chung-Hwan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6472-7511","authenticated-orcid":false,"given":"Natthinee","family":"Charatcharoenwitthaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.afos.2025.11.001_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American society for bone and mineral research","volume":"29","author":"Shane","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.afos.2025.11.001_bib2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.carj.2014.01.002","article-title":"Atypical femoral fractures: a teaching perspective","volume":"66","author":"Khan","year":"2015","journal-title":"Can Assoc Radiol J"},{"issue":"10","key":"10.1016\/j.afos.2025.11.001_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10681","article-title":"Incidence of atypical femoral fractures in patients on osteoporosis Therapy-A registry-based cohort study","volume":"6","author":"Everts-Graber","year":"2022","journal-title":"JBMR Plus"},{"issue":"5","key":"10.1016\/j.afos.2025.11.001_bib4","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1210\/clinem\/dgz295","article-title":"Medical management of patients after atypical femur fractures: a systematic review and recommendations from the European calcified tissue society","volume":"105","author":"van de Laarschot","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.afos.2025.11.001_bib5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","volume":"5","author":"Bone","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.afos.2025.11.001_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ecl.2016.09.009","article-title":"Drug-related adverse events of osteoporosis therapy","volume":"46","author":"Khan","year":"2017","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"22","key":"10.1016\/j.afos.2025.11.001_bib7","first-page":"2189","article-title":"Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates","volume":"383","author":"Black","year":"2020","journal-title":"Reply. N Engl J Med."},{"issue":"2","key":"10.1016\/j.afos.2025.11.001_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.afos.2023.06.001","article-title":"Summary of the thai Osteoporosis Foundation (TOPF) clinical practice guideline on the diagnosis and management of osteoporosis 2021","volume":"9","author":"Charatcharoenwitthaya","year":"2023","journal-title":"Osteoporos Sarcopenia"},{"issue":"2","key":"10.1016\/j.afos.2025.11.001_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.afos.2023.06.002","article-title":"A summary of the Malaysian clinical Practice guidelines on the management of postmenopausal osteoporosis, 2022","volume":"9","author":"Ong","year":"2023","journal-title":"Osteoporos Sarcopenia"},{"issue":"Suppl 2","key":"10.1016\/j.afos.2025.11.001_bib10","first-page":"1","article-title":"OSHK guideline for clinical management of postmenopausal osteoporosis in Hong Kong","volume":"30","author":"Ip","year":"2024","journal-title":"Hong Kong Med J"},{"issue":"3","key":"10.1016\/j.afos.2025.11.001_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.11005\/jbm.2023.30.3.209","article-title":"Position statement: atypical femoral fracture from the Korean society for bone and mineral research in 2023","volume":"30","author":"Nho","year":"2023","journal-title":"J Bone Metab"},{"issue":"3","key":"10.1016\/j.afos.2025.11.001_bib12","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.afos.2025.11.001_bib13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1302\/0301-620X.89B3.18146","article-title":"Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution","volume":"89","author":"Goh","year":"2007","journal-title":"J Bone Joint Surg Br"},{"issue":"8","key":"10.1016\/j.afos.2025.11.001_bib14","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00198-008-0805-x","article-title":"Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study","volume":"20","author":"Lenart","year":"2009","journal-title":"Osteoporos Int"},{"issue":"11","key":"10.1016\/j.afos.2025.11.001_bib15","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American society for bone and mineral research","volume":"25","author":"Shane","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1016\/j.afos.2025.11.001_bib16","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/jbmr.1719","article-title":"Incidence of atypical nontraumatic diaphyseal fractures of the femur","volume":"27","author":"Dell","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.afos.2025.11.001_bib17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3109\/17453674.2015.1004149","article-title":"Risk of atypical femoral fracture during and after bisphosphonate use","volume":"86","author":"Schilcher","year":"2015","journal-title":"Acta Orthop"},{"issue":"1","key":"10.1016\/j.afos.2025.11.001_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12603-015-0652-3","article-title":"Epidemiology and postoperative outcomes of atypical femoral fractures in older adults: a systematic review","volume":"21","author":"Khow","year":"2017","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.afos.2025.11.001_bib19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bone.2016.01.002","article-title":"The association of race\/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy","volume":"85","author":"Lo","year":"2016","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.afos.2025.11.001_bib20","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2018.33.e38","article-title":"Incidence rate of atypical femoral fracture after bisphosphonates treatment in Korea","volume":"33","author":"Lee","year":"2018","journal-title":"J Korean Med Sci."},{"issue":"6","key":"10.1016\/j.afos.2025.11.001_bib21","first-page":"635","article-title":"Prevalence of atypical femoral fractures in Thai patients at a single institution","volume":"97","author":"Luangkittikong","year":"2014","journal-title":"J Med Assoc Thai"},{"issue":"8","key":"10.1016\/j.afos.2025.11.001_bib22","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJMoa1916525","article-title":"Atypical Femur fracture risk versus fragility fracture prevention with bisphosphonates","volume":"383","author":"Black","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.afos.2025.11.001_bib23","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/jbmr.308","article-title":"An atypical subtrochanteric femoral fracture from pycnodysostosis: a lesson from nature","volume":"26","author":"Yates","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.afos.2025.11.001_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.5704\/MOJ.1303.002","article-title":"Spontaneous subtrochanteric femoral stress fracture related to alendronate : a case report","volume":"7","author":"Chew","year":"2013","journal-title":"Malays Orthop J"},{"issue":"2","key":"10.1016\/j.afos.2025.11.001_bib25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1756-185X.2009.01396.x","article-title":"Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium","volume":"12","author":"Lee","year":"2009","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.afos.2025.11.001_bib26","doi-asserted-by":"crossref","DOI":"10.15605\/jafes.040.S1.118","article-title":"Unmasking atypical femoral fractures in osteoporosis: a case series of high-risk patients","author":"Cheong","year":"2025","journal-title":"J ASEAN Fed Endocr Soc"},{"issue":"4","key":"10.1016\/j.afos.2025.11.001_bib27","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4132\/jptm.2020.05.14","article-title":"Atypical femoral neck fracture after prolonged bisphosphonate therapy","volume":"54","author":"Kim","year":"2020","journal-title":"J Pathol Transl Med"},{"issue":"5","key":"10.1016\/j.afos.2025.11.001_bib28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00774-012-0358-0","article-title":"Low-energy diaphyseal femoral fractures associated with bisphosphonate use and severe curved femur: a case series","volume":"30","author":"Sasaki","year":"2012","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"10.1016\/j.afos.2025.11.001_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12020-023-03608-z","article-title":"Clinical characteristics, densitometric parameters and outcomes of patients with atypical femoral fractures related to bisphosphonate treatment for osteoporosis","volume":"84","author":"Wong","year":"2024","journal-title":"Endocrine"},{"issue":"9","key":"10.1016\/j.afos.2025.11.001_bib30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1302\/2058-5241.3.170070","article-title":"The enigma of atypical femoral fractures: a summary of current knowledge","volume":"3","author":"Larsen","year":"2018","journal-title":"EFORT Open Rev"},{"issue":"3","key":"10.1016\/j.afos.2025.11.001_bib31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00774-014-0591-9","article-title":"The incidence of and risk factors for developing atypical femoral fractures in Japan","volume":"33","author":"Saita","year":"2015","journal-title":"J Bone Miner Metab"},{"issue":"11","key":"10.1016\/j.afos.2025.11.001_bib32","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1007\/s00198-017-4169-y","article-title":"Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center","volume":"28","author":"Koh","year":"2017","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.afos.2025.11.001_bib33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bone.2012.02.632","article-title":"Clinical correlates of atypical femoral fracture","volume":"51","author":"Lo","year":"2012","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.afos.2025.11.001_bib34","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician's guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos Int"},{"issue":"Suppl 1","key":"10.1016\/j.afos.2025.11.001_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","article-title":"American Association of clinical endocrinologists\/American college of endocrinology clinical practice guidelines for the diagnosis and treatment of Postmenopausal Osteoporosis-2020 update","volume":"26","author":"Camacho","year":"2020","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1016\/j.afos.2025.11.001_bib36","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00198-018-4506-9","article-title":"A proposal for an atypical femur fracture treatment and prevention clinical practice guideline","volume":"29","author":"Dell","year":"2018","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.afos.2025.11.001_bib37","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jocd.2019.07.003","article-title":"Detection of atypical femur fractures","volume":"22","author":"Cheung","year":"2019","journal-title":"J Clin Densitom"},{"issue":"5","key":"10.1016\/j.afos.2025.11.001_bib38","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1302\/0301-620X.92B5.22941","article-title":"A rational approach to management of alendronate-related subtrochanteric fractures","volume":"92","author":"Das De","year":"2010","journal-title":"J Bone Joint Surg Br"},{"issue":"2","key":"10.1016\/j.afos.2025.11.001_bib39","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.injury.2007.08.036","article-title":"An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?","volume":"39","author":"Kwek","year":"2008","journal-title":"Injury"},{"issue":"5","key":"10.1016\/j.afos.2025.11.001_bib40","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/BOT.0b013e318172841c","article-title":"Low-energy femoral shaft fractures associated with alendronate use","volume":"22","author":"Neviaser","year":"2008","journal-title":"J Orthop Trauma"},{"issue":"12","key":"10.1016\/j.afos.2025.11.001_bib41","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMc0707493","article-title":"Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate","volume":"358","author":"Lenart","year":"2008","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.afos.2025.11.001_bib42","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.2106\/JBJS.H.01774","article-title":"Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy","volume":"91","author":"Capeci","year":"2009","journal-title":"J Bone Joint Surg Am"},{"issue":"8","key":"10.1016\/j.afos.2025.11.001_bib43","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00198-023-06768-w","article-title":"The effect of teriparatide on fracture healing after atypical femoral fracture: a systematic review and meta-analysis","volume":"34","author":"Byun","year":"2023","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.afos.2025.11.001_bib44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.11005\/jbm.2020.27.3.167","article-title":"Does teriparatide improve fracture union?: a systematic review","volume":"27","author":"Yoon","year":"2020","journal-title":"J Bone Metab."},{"issue":"4","key":"10.1016\/j.afos.2025.11.001_bib45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.11005\/jbm.2015.22.4.183","article-title":"Effect of teriparatide on healing of atypical femoral fractures: a systemic review","volume":"22","author":"Im","year":"2015","journal-title":"J Bone Metab"},{"issue":"3","key":"10.1016\/j.afos.2025.11.001_bib46","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1302\/0301-620X.99B3.BJJ-2016-0276.R2","article-title":"Atypical femoral fractures related to bisphosphonate treatment: issues and controversies related to their surgical management","volume":"99-b","author":"Koh","year":"2017","journal-title":"Bone Joint Lett J"},{"issue":"8","key":"10.1016\/j.afos.2025.11.001_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.injury.2023.110909","article-title":"Should nails be locked dynamically or statically in atypical femoral fractures? - a radiological analysis of time to union and reoperations in 236 displaced fractures with 4 years average follow-up","volume":"54","author":"Fang","year":"2023","journal-title":"Injury"},{"issue":"12","key":"10.1016\/j.afos.2025.11.001_bib48","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1210\/jc.2010-1571","article-title":"Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis","volume":"95","author":"Abrahamsen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.afos.2025.11.001_bib49","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1007\/s11999-012-2412-6","article-title":"Bisphosphonate-associated femur fractures have high complication rates with operative fixation","volume":"470","author":"Prasarn","year":"2012","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"10.1016\/j.afos.2025.11.001_bib50","first-page":"186","article-title":"The outcome of surgically treated femur fractures associated with long-term bisphosphonate use","volume":"71","author":"Weil","year":"2011","journal-title":"J Trauma"},{"issue":"6","key":"10.1016\/j.afos.2025.11.001_bib51","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.injury.2016.02.026","article-title":"Surgical tips of intramedullary nailing in severely bowed femurs in atypical femur fractures: simulation with 3D printed model","volume":"47","author":"Park","year":"2016","journal-title":"Injury"},{"issue":"11","key":"10.1016\/j.afos.2025.11.001_bib52","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00402-017-2764-1","article-title":"Surgical outcomes of intramedullary nailing for diaphyseal atypical femur fractures: is it safe to modify a nail entry in bowed femur?","volume":"137","author":"Kim","year":"2017","journal-title":"Arch Orthop Trauma Surg"},{"issue":"4","key":"10.1016\/j.afos.2025.11.001_bib53","doi-asserted-by":"crossref","first-page":"202","DOI":"10.5371\/hp.2018.30.4.202","article-title":"Surgical treatment of the atypical femoral fracture: overcoming femoral bowing","volume":"30","author":"Lee","year":"2018","journal-title":"Hip Pelvis"},{"issue":"1","key":"10.1016\/j.afos.2025.11.001_bib54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/jbmr.4461","article-title":"Fracture risk following an atypical femoral fracture","volume":"37","author":"B\u00e9gin","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.afos.2025.11.001_bib55","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bone.2011.06.027","article-title":"Prolonged bisphosphonate release after treatment in women with osteoporosis. Relationship with bone turnover","volume":"49","author":"Peris","year":"2011","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.afos.2025.11.001_bib56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.4453","article-title":"Bone mineral density and bone turnover 10 years after a single 5 mg dose or two 5-Yearly lower doses of zoledronate in osteopenic older women: an open-label extension of a randomized controlled trial","volume":"37","author":"Grey","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"11","key":"10.1016\/j.afos.2025.11.001_bib57","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/jbmr.448","article-title":"Bone remodeling in postmenopausal women who discontinued denosumab treatment: off-treatment biopsy study","volume":"26","author":"Brown","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.afos.2025.11.001_bib58","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11914-022-00771-6","article-title":"Denosumab discontinuation","volume":"21","author":"S\u00f8lling","year":"2023","journal-title":"Curr Osteoporos Rep"},{"issue":"11","key":"10.1016\/j.afos.2025.11.001_bib59","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/jbmr.4705","article-title":"Multiple vertebral fractures after denosumab discontinuation: FREEDOM and FREEDOM extension trials additional post hoc analyses","volume":"37","author":"Cosman","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.afos.2025.11.001_bib60","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00198-022-06648-9","article-title":"Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study","volume":"34","author":"Tutaworn","year":"2023","journal-title":"Osteoporos Int"},{"issue":"7","key":"10.1016\/j.afos.2025.11.001_bib61","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/jbmr.4305","article-title":"Treatment with zoledronate subsequent to denosumab in osteoporosis: a 2-Year randomized study","volume":"36","author":"S\u00f8lling","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.afos.2025.11.001_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-37944-x","article-title":"Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system","volume":"13","author":"Xiao","year":"2023","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.afos.2025.11.001_bib63","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3949\/ccjm.85a.16090","article-title":"Idiopathic hypercalciuria: can we prevent stones and protect bones?","volume":"85","author":"Ryan","year":"2018","journal-title":"Cleve Clin J Med"},{"issue":"4","key":"10.1016\/j.afos.2025.11.001_bib64","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvad013","article-title":"The eucalcemic patient with elevated parathyroid hormone levels","volume":"7","author":"Shaker","year":"2023","journal-title":"J Endocr Soc"},{"issue":"3","key":"10.1016\/j.afos.2025.11.001_bib65","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/EJE-15-0118","article-title":"Management of endocrine disease: secondary osteoporosis: pathophysiology and management","volume":"173","author":"Mirza","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.afos.2025.11.001_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11914-022-00717-y","article-title":"Evaluating patients for secondary causes of osteoporosis","volume":"20","author":"Lewiecki","year":"2022","journal-title":"Curr Osteoporos Rep"},{"issue":"9999","key":"10.1016\/j.afos.2025.11.001_bib67","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(15)61120-5","article-title":"Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-switch study): extension of a randomised controlled trial","volume":"386","author":"Leder","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.afos.2025.11.001_bib68","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bone.2018.10.020","article-title":"Administration of teriparatide for four years cyclically compared to two years daily in treatment na\u00efve and alendronate treated women","volume":"120","author":"Cosman","year":"2019","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.afos.2025.11.001_bib69","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/jbmr\/zjae159","article-title":"Atypical fractures at non-classical sites associated with anti-resorptive therapy: a systematic review","volume":"39","author":"Collins","year":"2024","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.afos.2025.11.001_bib70","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jbmr.3337","article-title":"Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension","volume":"33","author":"Cummings","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.afos.2025.11.001_bib71","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12891-016-1086-8","article-title":"Management of atypical femoral fracture: a scoping review and comprehensive algorithm","volume":"17","author":"Toro","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"issue":"10","key":"10.1016\/j.afos.2025.11.001_bib72","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1302\/0301-620X.101B10.BJJ-2019-0599.R2","article-title":"Periprosthetic atypical femoral fractures exist and are associated with duration of bisphosphonate therapy","volume":"101-b","author":"MacKenzie","year":"2019","journal-title":"Bone Joint Lett J"},{"key":"10.1016\/j.afos.2025.11.001_bib73","doi-asserted-by":"crossref","DOI":"10.1177\/21514593221090392","article-title":"Surgical and pharmacological management of periprosthetic atypical femoral fractures: a narrative literature review","volume":"13","author":"Troiano","year":"2022","journal-title":"Geriatr Orthop Surg Rehabil"},{"issue":"3","key":"10.1016\/j.afos.2025.11.001_bib74","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00402-023-05171-8","article-title":"The effect of teriparatide on patients with atypical femur fractures: a systematic review and meta-analysis","volume":"144","author":"Salamah","year":"2024","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.afos.2025.11.001_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115516","article-title":"Treatment of postmenopausal osteoporosis with bone-forming and antiresorptive treatments: combined and sequential approaches","volume":"139","author":"Langdahl","year":"2020","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.afos.2025.11.001_bib76","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00198-021-06174-0","article-title":"Romosozumab and antiresorptive treatment: the importance of treatment sequence","volume":"33","author":"Cosman","year":"2022","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.afos.2025.11.001_bib77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.afos.2024.02.001","article-title":"Asia-Pacific consensus on long-term and sequential therapy for osteoporosis","volume":"10","author":"Tai","year":"2024","journal-title":"Osteoporos Sarcopenia"},{"issue":"5","key":"10.1016\/j.afos.2025.11.001_bib78","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2214\/AJR.11.7442","article-title":"Frequency of incomplete atypical femoral fractures in asymptomatic patients on long-term bisphosphonate therapy","volume":"198","author":"La","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.afos.2025.11.001_bib79","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10607","article-title":"Asian ethnicity and femoral geometry in atypical femur fractures: independent or interdependent risk factors?","volume":"6","author":"Dhanekula","year":"2022","journal-title":"JBMR Plus"},{"issue":"12","key":"10.1016\/j.afos.2025.11.001_bib80","article-title":"Age- and gender-related femoral bowing analysis in the Korean population and features for clinical applications","volume":"60","author":"Kim","year":"2024","journal-title":"Medicina (Kaunas)"},{"issue":"3","key":"10.1016\/j.afos.2025.11.001_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12031038","article-title":"Bilateral atypical femoral fractures after bisphosphonate treatment for osteoporosis: a literature review","volume":"12","author":"Hwang","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.afos.2025.11.001_bib82","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1210\/er.2018-00001","article-title":"Atypical Femur fractures: review of epidemiology, relationship to bisphosphonates, prevention, and clinical management","volume":"40","author":"Black","year":"2019","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.afos.2025.11.001_bib83","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11657-022-01166-x","article-title":"Atypical femoral fracture in a bisphosphonate-na\u00efve patient on denosumab for osteoporosis","volume":"17","author":"Kumar","year":"2022","journal-title":"Arch Osteoporos"}],"container-title":["Osteoporosis and Sarcopenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405525525001505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405525525001505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:49:36Z","timestamp":1765975776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405525525001505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2405525525001505"],"URL":"https:\/\/doi.org\/10.1016\/j.afos.2025.11.001","relation":{},"ISSN":["2405-5255"],"issn-type":[{"value":"2405-5255","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asian Federation of Osteoporosis Societies 2025 consensus on atypical femoral fractures in patients with osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Osteoporosis and Sarcopenia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.afos.2025.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Korean Society of Osteoporosis. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}